Johnson & Johnson Begins Final Stage of Testing for Its Single-Dose COVID-19 Vaccine

Johnson & Johnson began its final round of testing for its COVID-19 vaccine Wednesday.

The study is one of the most expansive to occur so far, involving 60,000 volunteers across the United States, Argentina, Brazil, Chile, Peru, Mexico and South Africa, the Associated Press reported. The vaccine is the latest to begin its final testing phase, joining candidates developed by Moderna and Pfizer, and is the only vaccine that would be administered as a single dose.

Read More

Johnson & Johnson Reaches $20.4 Million Settlement with Ohio Counties Over Opioid Deaths

Johnson & Johnson, the medical device company, agreed to a $20.4 million settlement with two Ohio counties in a federal lawsuit over opioid deaths. There are currently more than 100 lawsuits against pharmaceutical companies in the state seeking damages for their role in causing the opioid crisis.

Read More

Seven Pharma Execs Who Testified Before Congress Tuesday Make a Combined $116 Million Per Year

by Evie Fordham   Five of the seven pharmaceutical companies who sent executives to testify on drug pricing before the Senate Finance Committee Tuesday have the top-25 highest-paid pharma CEOs for companies in the S&P 500. CEOs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer and Sanofi plus Johnson & Johnson’s…

Read More